Manar Maamoun Ashour
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Manar Maamoun Ashour has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Anas Askoura
Department of Otorhinolaryngology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
3 shared publications - Doaa Maamoun Ashour
Department of Ophthalmology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
2 shared publications - Mohamed Ibrahim Saleh
Ophthalmology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
2 shared publications - Togan Taha
Department of radiology, Ain Shams University, Cairo, Egypt.
2 shared publications - Ahmed Abdel Khalek Abdel Razek
Department of Diagnostic Radiology, Mansoura Faculty of Medicine, Mansoura University, Mansoura, Egypt
1 shared publication - Ahmed Samy Abdelrahman
Radiology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
1 shared publication
Latest Publications
- Open Access
- 1 September 2025
- Published by Egyptian Knowledge Bank in Ain Shams Medical Journal
- Vol. 76 (3) , 654-663
Diagnostic Performance of Brain Tumor Reporting and Data System (BT-RADS) in Post Treatment Surveillance of Brain Glioma
Background: Currently, structured reporting aims to revolutionize radiology's role in enhancing patient management by improving the clarity of imaging interpretation, unifying the terms used, and simply explaining scoring-linked management via the development of brain tumor reporting and data system (BT-RADS).Objective: To assess the value of using the BT-RADS scoring system for post-treatment imaging follow-up in patients with brain glioma.Methods: This retrospective study comprised fifty-four patients diagnosed to have brain glioma. These patients underwent sequential follow-up MRI scans over a period of twelve months. The imaging findings including enhancing component, FLAIR signal and mass effect of the MRI scans were analyzed and interpreted in the form of a checklist and eventually a BT-RADS score was given. The BT-RADS score diagnostic performance at 3 and 6 months to predict the final patient outcome were compared using the 12-month follow-up as the gold standard of reference.Results: BT-RADS scoring at six months post-treatment showed the higher diagnostic performance in predicting final patient outcome as compared to the performance of the system at three months, with a sensitivity of 77.8% versus 72.2%, and a specificity of 94.4% versus 88.9%. Among the individual MRI diagnostic features included in this system, assessment of enhancement showed the highest performance with a sensitivity and a specificity of 72.2% and 91.7% respectively.Conclusion: The BT-RADS scoring system demonstrates robust diagnostic accuracy for predicting treatment response at the 12-month follow-up, supporting its routine use in the longitudinal assessment of patients with brain gliomas.
- 1 September 2025
- Published by Egyptian Knowledge Bank in Ain Shams Medical Journal
- Vol. 76 (3) , 654-663
Open AccessDiagnostic Performance of Brain Tumor Reporting and Data System (BT-RADS) in Post Treatment Surveillance of Brain Glioma
Background: Currently, structured reporting aims to revolutionize radiology's role in enhancing patient management by improving the clarity of imaging interpretation, unifying the terms used, and simply explaining scoring-linked management via the development of brain tumor reporting and data system (BT-RADS).Objective: To assess the value of using the BT-RADS scoring system for post-treatment imaging follow-up in patients with brain glioma.Methods: This retrospective study comprised fifty-four patients diagnosed to have brain glioma. These patients underwent sequential follow-up MRI scans over a period of twelve months. The imaging findings including enhancing component, FLAIR signal and mass effect of the MRI scans were analyzed and interpreted in the form of a checklist and eventually a BT-RADS score was given. The BT-RADS score diagnostic performance at 3 and 6 months to predict the final patient outcome were compared using the 12-month follow-up as the gold standard of reference.Results: BT-RADS scoring at six months post-treatment showed the higher diagnostic performance in predicting final patient outcome as compared to the performance of the system at three months, with a sensitivity of 77.8% versus 72.2%, and a specificity of 94.4% versus 88.9%. Among the individual MRI diagnostic features included in this system, assessment of enhancement showed the highest performance with a sensitivity and a specificity of 72.2% and 91.7% respectively.Conclusion: The BT-RADS scoring system demonstrates robust diagnostic accuracy for predicting treatment response at the 12-month follow-up, supporting its routine use in the longitudinal assessment of patients with brain gliomas.
- 17 April 2024
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 76 (4) , 2987-2994
Nasal Septum Deviation in Patients with Acute Invasive Fungal Rhinosinusitis in a Tertiary Care Hospital: A Cross-Sectional Study
This is a retrospective study exploring the demographics and the role of nasal septum deviation in acute invasive fungal rhinosinusitis (AIFS); and if this deviation contributes to the laterality predilection of this opportunistic infection. Fifty-six craniofacial CT scans were evaluated by two radiologists blinded to the clinical data and outcome for laterality of the disease; and nasal septal deviation (NSD). NSD was graded based on the measured septal angle of deviation into mild, moderate, and severe and furtherly classified into one of seven types based on Mladina’s classification. High prevalence of remarkable nasal septum deviation existed in our population with AIFS, with type 7 Mldina NSD represented the most prevalent in this population. We found no significant statistical relation between the side of deviation and the initial side of the fungal disease. We recommend screening for early manifestations of AIFS in similar debilitated patients; with high degrees of nasal septum deviation for considering it as an anatomical risk factor.
- 17 April 2024
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 76 (4) , 2987-2994
Nasal Septum Deviation in Patients with Acute Invasive Fungal Rhinosinusitis in a Tertiary Care Hospital: A Cross-Sectional Study
This is a retrospective study exploring the demographics and the role of nasal septum deviation in acute invasive fungal rhinosinusitis (AIFS); and if this deviation contributes to the laterality predilection of this opportunistic infection. Fifty-six craniofacial CT scans were evaluated by two radiologists blinded to the clinical data and outcome for laterality of the disease; and nasal septal deviation (NSD). NSD was graded based on the measured septal angle of deviation into mild, moderate, and severe and furtherly classified into one of seven types based on Mladina’s classification. High prevalence of remarkable nasal septum deviation existed in our population with AIFS, with type 7 Mldina NSD represented the most prevalent in this population. We found no significant statistical relation between the side of deviation and the initial side of the fungal disease. We recommend screening for early manifestations of AIFS in similar debilitated patients; with high degrees of nasal septum deviation for considering it as an anatomical risk factor.
- 29 January 2023
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 75 (S1) , 901-905
Endoscopic Assisted Caldwell-Luc Approach for Total Excision of an Extensive Aneurysmal Bony Cyst of the Maxillary Sinus
Aneurysmal bone cysts (ABCs) are uncommon lesions in head and neck area that could be primary or secondary in origin. The main problem with the traditional curettage and debridement is the high rates of recurrence, and cosmetic disfigurement with the open approach. In this article, we describe the use of a combined endoscopic sinus surgery and endoscopic assisted Caldwell approach to achieve a complete surgical excision of left maxillary sinus ABC extending to the left infratemporal fossa, and to avoid facial disfigurement in a 13-year-old female patient presented to our hospital with diplopia, facial pain, and headache. The patient had uneventful post-operative recovery period with resolution of the presenting symptoms with no complications. Hence, we recommend this combined endoscopic surgical approach in such cases.
- 29 January 2023
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 75 (S1) , 901-905
Endoscopic Assisted Caldwell-Luc Approach for Total Excision of an Extensive Aneurysmal Bony Cyst of the Maxillary Sinus
Aneurysmal bone cysts (ABCs) are uncommon lesions in head and neck area that could be primary or secondary in origin. The main problem with the traditional curettage and debridement is the high rates of recurrence, and cosmetic disfigurement with the open approach. In this article, we describe the use of a combined endoscopic sinus surgery and endoscopic assisted Caldwell approach to achieve a complete surgical excision of left maxillary sinus ABC extending to the left infratemporal fossa, and to avoid facial disfigurement in a 13-year-old female patient presented to our hospital with diplopia, facial pain, and headache. The patient had uneventful post-operative recovery period with resolution of the presenting symptoms with no complications. Hence, we recommend this combined endoscopic surgical approach in such cases.
- 1 September 2021
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 48 (5) , 319-324
Imaging spectrum of acute invasive fungal rhino-orbital-cerebral sinusitis in COVID-19 patients: A case series and a review of literature
- 1 September 2021
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 48 (5) , 319-324
Imaging spectrum of acute invasive fungal rhino-orbital-cerebral sinusitis in COVID-19 patients: A case series and a review of literature
- 11 March 2021
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 42 (6) , 1123-1129
MRI Posttreatment Surveillance for Head and Neck Squamous Cell Carcinoma: Proposed MR NI-RADS Criteria
BACKGROUND AND PURPOSE: The current Neck Imaging Reporting and Data System (NI-RADS) criteria were designed for contrast-enhanced CT with or without PET. Prior studies have revealed the capability of DWI and T2 signal intensity in distinguishing locoregional tumor residual and recurrence from posttreatment benign findings in head and neck cancers. We aimed to propose MR imaging NI-RADS criteria by adding diffusion criteria and T2 signal intensity to the American College of Radiology NI-RADS template. MATERIALS AND METHODS: This retrospective study included 69 patients with head and neck squamous cell carcinoma (HNSCC) who underwent posttreatment contrast-enhanced MRI imaging surveillance using a 1.5T scanner. The scans were interpreted by 2 neuroradiologists. Image analysis assessed the primary tumor site using the current American College of Radiology NI-RADS morphologic lexicon (mainly designed for contrast-enhanced CT with or without PET). NI-RADS rescoring was then performed based on our proposed criteria using T2 signal and diffusion features. The reference standard was a defined set of criteria, including clinical and imaging follow-up and pathologic assessment. RESULTS: Imaging assessment of treated HNSCC at the primary tumor site using T2 signal intensity and diffusion features as modifying rules to NI-RADS showed higher sensitivity, specificity, positive predictive value, negative predictive value, and accuracy (92.3%, 90.7%, 85.7%, 95.1%, and 91.3%, respectively) compared with the current NI-RADS lexicon alone (84.6%, 81.4%, 73.3%, 89.8%, and 82.6%, respectively). CONCLUSIONS: The addition of diffusion features and T2 signal to the American College of Radiology NI-RADS criteria for the primary tumor site enhances the specificity, sensitivity, positive predictive value, negative predictive value, and NI-RADS accuracy.
- 11 March 2021
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 42 (6) , 1123-1129
MRI Posttreatment Surveillance for Head and Neck Squamous Cell Carcinoma: Proposed MR NI-RADS Criteria
BACKGROUND AND PURPOSE: The current Neck Imaging Reporting and Data System (NI-RADS) criteria were designed for contrast-enhanced CT with or without PET. Prior studies have revealed the capability of DWI and T2 signal intensity in distinguishing locoregional tumor residual and recurrence from posttreatment benign findings in head and neck cancers. We aimed to propose MR imaging NI-RADS criteria by adding diffusion criteria and T2 signal intensity to the American College of Radiology NI-RADS template. MATERIALS AND METHODS: This retrospective study included 69 patients with head and neck squamous cell carcinoma (HNSCC) who underwent posttreatment contrast-enhanced MRI imaging surveillance using a 1.5T scanner. The scans were interpreted by 2 neuroradiologists. Image analysis assessed the primary tumor site using the current American College of Radiology NI-RADS morphologic lexicon (mainly designed for contrast-enhanced CT with or without PET). NI-RADS rescoring was then performed based on our proposed criteria using T2 signal and diffusion features. The reference standard was a defined set of criteria, including clinical and imaging follow-up and pathologic assessment. RESULTS: Imaging assessment of treated HNSCC at the primary tumor site using T2 signal intensity and diffusion features as modifying rules to NI-RADS showed higher sensitivity, specificity, positive predictive value, negative predictive value, and accuracy (92.3%, 90.7%, 85.7%, 95.1%, and 91.3%, respectively) compared with the current NI-RADS lexicon alone (84.6%, 81.4%, 73.3%, 89.8%, and 82.6%, respectively). CONCLUSIONS: The addition of diffusion features and T2 signal to the American College of Radiology NI-RADS criteria for the primary tumor site enhances the specificity, sensitivity, positive predictive value, negative predictive value, and NI-RADS accuracy.
- Open Access
- 18 August 2020
- Published by Springer Nature in Cancer Imaging
- Vol. 20 (1) , 1-10
Interreader reproducibility of the Neck Imaging Reporting and Data system (NI-RADS) lexicon for the detection of residual/recurrent disease in treated head and neck squamous cell carcinoma (HNSCC)
Background: To evaluate the inter- and intrareader agreement and reproducibility of the NI-RADS scoring system and lexicon with contrast-enhanced computed tomography (CECT) and contrast-enhanced magnetic resonance imaging (CEMRI). Methods: This retrospective study included 97 CECT and CEMRI scans from 58 treated cases of head and neck squamous cell carcinoma (HNSCC) after the exclusion of head and neck cancers (HNCs) other than SCC and noncontrast and poor quality CT and MRI scans, with a total of 111 primary targets and 124 lymph node (LN) targets. Two experienced readers independently scored the likelihood of residual/recurrence for these targets based on the NI-RADS criteria and filled in report templates for NI-RADS lexicon diagnostic features. Inter- and intraobserver reproducibility was assessed with Cohen’s kappa, and the percent agreement was calculated. Results: Almost perfect interreader agreement was found for the final NI-RADS category of the primary lesions and LNs, with K = 0.808 and 0.806, respectively. Better agreement was found for CT than for MRI (K = 0.843 and 0.77, respectively, P value 0.001). There was almost perfect agreement for excluding tissue enhancement (K = 0.826, 95% CI = 0.658–0.993, P value 0.001), with a percent agreement of 96.4%, and substantial agreement for discrete nodular and diffuse mucosal enhancement (K = 0.826, 95% CI = 0.658–0.993, P value 0.001), with a percent agreement of 96.4%. There was fair agreement for focal mucosal nonmass and deep ill-defined enhancement. The intrareader agreement was almost perfect for most of the rated features (K ranging from 0.802 to 1), with the exception of enlarging discrete nodule/mass and focal mucosal nonmass-like enhancement, which had substantial intraobserver agreement (K ranging from 0.768 to 0.786). Conclusion: The individual features of NI-RADS show variable degrees of confidence; however, the overall NI-RADS category was not significantly affected.
- 18 August 2020
- Published by Springer Nature in Cancer Imaging
- Vol. 20 (1) , 1-10
Open AccessInterreader reproducibility of the Neck Imaging Reporting and Data system (NI-RADS) lexicon for the detection of residual/recurrent disease in treated head and neck squamous cell carcinoma (HNSCC)
Background: To evaluate the inter- and intrareader agreement and reproducibility of the NI-RADS scoring system and lexicon with contrast-enhanced computed tomography (CECT) and contrast-enhanced magnetic resonance imaging (CEMRI). Methods: This retrospective study included 97 CECT and CEMRI scans from 58 treated cases of head and neck squamous cell carcinoma (HNSCC) after the exclusion of head and neck cancers (HNCs) other than SCC and noncontrast and poor quality CT and MRI scans, with a total of 111 primary targets and 124 lymph node (LN) targets. Two experienced readers independently scored the likelihood of residual/recurrence for these targets based on the NI-RADS criteria and filled in report templates for NI-RADS lexicon diagnostic features. Inter- and intraobserver reproducibility was assessed with Cohen’s kappa, and the percent agreement was calculated. Results: Almost perfect interreader agreement was found for the final NI-RADS category of the primary lesions and LNs, with K = 0.808 and 0.806, respectively. Better agreement was found for CT than for MRI (K = 0.843 and 0.77, respectively, P value 0.001). There was almost perfect agreement for excluding tissue enhancement (K = 0.826, 95% CI = 0.658–0.993, P value 0.001), with a percent agreement of 96.4%, and substantial agreement for discrete nodular and diffuse mucosal enhancement (K = 0.826, 95% CI = 0.658–0.993, P value 0.001), with a percent agreement of 96.4%. There was fair agreement for focal mucosal nonmass and deep ill-defined enhancement. The intrareader agreement was almost perfect for most of the rated features (K ranging from 0.802 to 1), with the exception of enlarging discrete nodule/mass and focal mucosal nonmass-like enhancement, which had substantial intraobserver agreement (K ranging from 0.768 to 0.786). Conclusion: The individual features of NI-RADS show variable degrees of confidence; however, the overall NI-RADS category was not significantly affected.